FindTrial
Sign In

Study on the Efficacy and Safety of Crocin Total Glycoside Tablets in the Treatment of Patients with Liver Cirrhosis

Study on the Efficacy and Safety of Crocin Total Glycoside Tablets in the Treatment of Patients with Liver Cirrhosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129155
Enrollment
Unknown
Registered
2026-07-31
Start date
2026-07-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis

Interventions

Treatment group:Oral Crocus sativus L. total glycoside tablets
control group:No

Sponsors

The first affiliated hospital of anhui medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with liver cirrhosis; 2.Age >= 18 years old; 3.Sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1.Patients complicated with other underlying diseases such as chronic obstructive pulmonary disease, myocardial infarction and liver cancer; 2.Patients with severe liver failure, severe cardiac insufficiency and severe renal insufficiency; 3.Pregnant or breastfeeding women; 4.Patients with missing indicators during follow-up, such as color Doppler ultrasound and liver function test results;

Design outcomes

Primary

MeasureTime frame
ALT;TBIL;AST;Elastography of liver;—

Secondary

MeasureTime frame
LDH;ALB;GGT;—

Countries

China

Contacts

Public ContactJunfa Yang

The Second Hospital of Anhui Medical University

yangjunfa@163.com+86 551 6667421

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026